跳至主要内容
临床试验/IRCT201603038307N14
IRCT201603038307N14已完成2 期

Evaluation of preventive effects of pentoxyfylline in contrast induced nephropathy in diabetic patients undergoing angioplasty

Vice chancellor for research, Tabriz University of Medical Sciences.0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 85 years(—)
性别
All

入选标准

  • Ischemic heart diseases and diabetic patients; age 18-85; undergoing of angioplasty with stent insertion; filling of consent form.

排除标准

  • Elevation of CK-MB and cTnI before PCI; history of CABG during last three months; history of previous MI; renal dysfunction (creatinine above 2.5 mg/dl); unsuccessful PCI; acute MI; cardiogenic shock; dialysis; pregnancy; inability in filling and understanding of the consent form; unconsented patients; patients who want to discontinue the study at any time.

研究者

发起方
Vice chancellor for research, Tabriz University of Medical Sciences.

相似试验